Emergent BioSolutions Company Profile

15:28 EDT 18th March 2018 | BioPortfolio

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therapeutics that assist the body’s immune system to prevent or treat disease. Our biodefense business focuses on immunobiotics for use against biological agents that are potential weapons of bioterrorism and biowarfare. Our marketed product, BioThrax® (Anthrax Vaccine Adsorbed), is the only vaccine approved by the U.S. Food and Drug Administration for the prevention of anthrax infection. In addition to BioThrax, our biodefense product portfolio includes a next generation anthrax vaccine program, which includes a product candidate in Phase I clinical development, and a botulism program with multiple product candidates in preclinical development. Our commercial business focuses on immunobiotics for use against infectious diseases and other medical conditions that have resulted in significant unmet or underserved public health needs. Our commercial product portfolio includes a typhoid vaccine candidate and a hepatitis B therapeutic vaccine candidate, both of which are in Phase II clinical development, a group B streptococcus vaccine candidate in Phase I clinical development and two vaccine candidates in preclinical development.


2273 Research Boulevard, Suite 400
United States of America


Phone: 301-795-1800
Fax: 301-795-1899

News Articles [62 Associated News Articles listed on BioPortfolio]

$175.41 Million in Sales Expected for Emergent Biosolutions, Inc. (EBS) This Quarter

Equities analysts predict that Emergent Biosolutions, Inc. will announce sales of $175.41 million for the current quarter, Zacks reports. Two analysts have provided estimates for Emergent Biosolutions...

Emergent BioSolutions strengthens manufacturing infrastructure with FDA-licensure

The US Food and Drug Administration (FDA) has approved Emergent BioSolutionsâ supplemental Biologics License Application (sBLA) for the manufacture of ACAM2000, the only FDA-licensed smallpox vaccine...

Emergent files paperwork for new immuno-oncology spin-off

Emergent BioSolutions announced April 15 that it has begun the formal process of separating some of its assets to form a separate entity, which will be known as Aptevo Therapeutics Inc. Read more..

Emergent BioSolutions: More Than An Emerging Biotech

Emergent files application to expand production of BioThrax

Emergent BioSolutions has filed a supplemental Biologics License Application with the U.S. Food and Drug Administration to scale up production of its anthrax vaccine BioThrax. Read more..

Emergent BioSolutions (EBS) Investor Presentation - Slideshow

Emergent eyes capacity boost for anti-nerve gas auto-injector

Emergent BioSolutions says it is looking to expand auto-injector manufacturing capacity due to growing demand for its nerve agent antidote product Trobigard.

Financial Report: Emergent BioSolutions

Contract manufacturing revenue up 29% in the quarter

Drugs and Medications [32 Associated Drugs and Medications listed on BioPortfolio]

Artemis alcohol-free antiseptic foam hand sanitizer [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Sanitizer

Artemis alcohol-free antiseptic foam hand [Artemis Bio-Solutions Inc]

ARTEMIS ALCOHOL-FREE Antiseptic Foam Hand Soap

Alprazolam [Sun Pharma Global FZE]

Alprazolam Tablets, USP CIV

Zolpidem tartrate [NorthStar Rx LLC]

These highlights do not include all the information needed to use zolpidem tartrate safely and effectively. See full prescribing information for zolpidem tartrate tablets.Zolpidem Tartrate Tablets CIV...

Zaleplon [Greenstone LLC]

PubMed Articles [133 Associated PubMed Articles listed on BioPortfolio]

Experience with Event Timing Does not Alter Emergent Timing: Further Evidence for Robustness of Event and Emergent Timing.

Although, event and emergent timings are thought of as mutually exclusive, significant correlations between tapping and circle drawing (Baer, Thibodeau, Gralnick, Li, & Penhune, 2013 ; Studenka, Zelaz...

Emergent cholecystectomy is superior to percutaneous cholecystostomy tube placement in critically ill patients with emergent calculous cholecystitis.

The role of percutaneous cholecystostomy (PC) is undefined in patients with multiple comorbidities presenting with emergent calculous cholecystitis (CC). This study compared outcomes between PC, lapar...

What can Parents' Self-report of Reading Difficulties Tell Us about Their Children's Emergent Literacy at School Entry?

Research has linked family risk (FR) of reading difficulties (RD) with children's difficulties in emergent literacy development. This study is the first to apply parents' self-report of RD as a proxy ...

Clinical and psychopathological features associated with treatment-emergent mania in bipolar-II depressed outpatients exposed to antidepressants.

Treatment-emergent affective switch (TEAS), including treatment-emergent mania (TEM), carry significant burden in the clinical management of bipolar depression, whereas the use of antidepressants rais...

Incidence and outcomes of emergent cardiac surgery during transfemoral transcatheter aortic valve implantation (TAVI): insights from the European Registry on Emergent Cardiac Surgery during TAVI (EuRECS-TAVI).

Life-threatening complications occur during transcatheter aortic valve implantation (TAVI) which can require emergent cardiac surgery (ECS). Risks and outcomes of patients needing ECS during or immedi...

Clinical Trials [125 Associated Clinical Trials listed on BioPortfolio]

Multifactorial Approach to Emergent Cerclage

Though cervical insufficiency is a common cause of second trimester pregnancy loss, the placement of an emergent cerclage in these patients is thought to improve perinatal outcomes. It is ...

Pre-hospital and Intra-hospital Temporal Delays in Patients Requiring Emergent Trauma Craniotomy

The investigators aim to retrospectively map the delays in the acute care of traumatic brain injury patients necessitating emergent craniotomies.

Assessing Treatment Emergent Suicidal Ideation in Patients With Major Depression

This study will develop a new methodology to evaluate any treatment-emergent suicidal ideation that might occur when an antidepressant treatment has been started and/or during times when d...

Fixed Versus Variable Dosing of 4-factor Prothrombin Complex Concentrate for Emergent Warfarin Reversal

The goal of this study is to determine if a fixed dose of 4-factor prothrombin complex concentrate (4FPCC) is as effective as the current standard of care. 4FPCC is used to reverse the eff...

Safety of Sugammadex for the Reversal of Neuromuscular Blockade in American Society of Anesthesiologists (ASA) Class 3 or 4 Participants (MK-8616-145)

This is a randomized, active comparator-controlled, parallel-group, multi-site, double-blind safety trial of sugammadex (MK-8616) for the reversal of neuromuscular blockade (NMB) induced b...

Companies [31 Associated Companies listed on BioPortfolio]

Emergent BioSolutions Inc.

Emergent BioSolutions Inc. is a biopharmaceutical company focused on the development, manufacture and commercialization of vaccines and antibody therapies that assist the bodyâ€...

Emergent BioSolutions

Emergent BioSolutions Inc. is a biopharmaceutical company dedicated to one simple mission—to protect life. We develop, manufacture and commercialize immunobiotics, consisting of vaccines and therape...

Emergent Health Corp.

Emergent Health Corp., a diversified biotechnology firm, is focused on the health and wellness industry. Using patented and patent pending nutritionally designed products, E...

Emergent Financial Group, Inc.

Emergent Financial Group provides investment banking services for early stage growth companies in healthcare. By specializing on innovative healthcare companies, Emergent has deve...

Pantec Biosolutions AG

Pantec Biosolutions specializes in precise skin microporation technology. Our proprietary P.L.E.A.S.E.® (Precise Laser EpidermAl SystEm) technology has been developed for:

More Information about "Emergent BioSolutions" on BioPortfolio

We have published hundreds of Emergent BioSolutions news stories on BioPortfolio along with dozens of Emergent BioSolutions Clinical Trials and PubMed Articles about Emergent BioSolutions for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Emergent BioSolutions Companies in our database. You can also find out about relevant Emergent BioSolutions Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...

Corporate Database Quicklinks

Searches Linking to this Company Record